Cargando…
An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
The chemokine receptor 4 (CXCR4) is a promising diagnostic and therapeutic target for the management of various cancers. CXCR4 has been utilized in immunotherapy, targeted drug delivery, and endoradiotherapy. Poly(amidoamine) [PAMAM] dendrimers are well-defined polymers with unique properties that h...
Autores principales: | Lesniak, Wojciech G., Azad, Babak Behnam, Chatterjee, Samit, Lisok, Ala, Pomper, Martin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953329/ https://www.ncbi.nlm.nih.gov/pubmed/35336029 http://dx.doi.org/10.3390/pharmaceutics14030655 |
Ejemplares similares
-
A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts
por: Azad, Babak Behnam, et al.
Publicado: (2016) -
A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
por: Chatterjee, Samit, et al.
Publicado: (2016) -
Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates
por: Pyreddy, Suneela, et al.
Publicado: (2014) -
Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
por: Narsireddy, Amreddy, et al.
Publicado: (2015) -
In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates
por: Najlah, Mohammad, et al.
Publicado: (2017)